SCHEDULE 13G/A: T. Rowe Price Trims Oscar Health Stake to 3.7%

T. Rowe Price Investment Management, Inc. has reported an amended beneficial ownership of 3.7% in Oscar Health Inc. Class A common stock.

Summary

• T. Rowe Price Investment Management, Inc. filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Oscar Health Inc. Class A common stock.
• As of the event date of September 30, 2025, T. Rowe Price beneficially owned 8,322,004 shares of Oscar Health Inc. Class A common stock.
• This aggregate amount represents 3.7% of the class of securities.
• T. Rowe Price holds sole voting power over 8,297,290 shares and sole dispositive power over 8,322,004 shares.
• The filing indicates that T. Rowe Price is an investment adviser and holds less than 5% of the class.

Sentiment

Score: 4

Explanation: The filing is a factual disclosure of beneficial ownership. While the reduction below 5% (implied by 'Amendment No. 1' and current percentage) could be interpreted as a slightly negative signal regarding the investor's conviction, the filing itself is neutral in tone and provides no operational or financial performance data for the issuer.

Positives

• NA

Negatives

• The filing indicates a beneficial ownership of 3.7%, which is below the 5% threshold typically requiring a Schedule 13G, suggesting a potential reduction in stake from a previous filing (implied by 'Amendment No. 1').

Risks

• NA

Future Outlook

NA

Industry Context

This filing reflects an institutional investor's adjusted position in a healthcare technology company, a sector that continues to attract significant investment interest due to ongoing digital transformation and innovation in healthcare services.

Stakeholder Impact

• Shareholders: Provides transparency regarding the ownership stake of a significant institutional investor, T. Rowe Price Investment Management, Inc.

Key Dates

Keywords

Oscar Health, T. Rowe Price, Beneficial Ownership, Schedule 13G, Common Stock, Investment Management, Healthcare Technology